Oral micronized progesterone combined with vaginal progesterone gel for luteal support

References

• Frydman R, Testart J, Giacomini P, Imbert MC, Martin E, Nahoul K. Hormonal and histological study of the luteal phase in women following aspiration of the preovulatory follicle. Fertil Steril 1982;38:312–317.
   PubMed Web of Science ®Google Scholar
• Balasch J, Creus M, Fábregues F, Carmona F, Casamitjana R, Peñarrubia J, Rivera F, Vanrell JA. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support. Gynecol Endocrinol 1995;9:51–58.
   PubMed Web of Science ®Google Scholar
• Fauser BC, Devroey P. Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab 2003;14:236–242.
   PubMed Web of Science ®Google Scholar
• Forman R, Belaisch-Allart J, Fries N, Hazout A, Testart J, Frydman R. Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation. Fertil Steril 1988;49:118–122.
   PubMed Web of Science ®Google Scholar
• Mui Lam P, Chun Cheung M, Ping Cheung L, Ingrid Lok H, John Haines C. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer. Gynecol Endocrinol 2008;24:674–680.
   PubMed Web of Science ®Google Scholar
• Martinez F, Coroleu B, Parera N, Alvarez M, Traver JM, Boada M, Barri PN. Human chorionic gonadotropin and intravaginal natural progesterone are equally effective for luteal phase support in IVF. Gynecol Endocrinol 2000;14: 316–320.
   PubMed Web of Science ®Google Scholar
• Nauhol K, Dehenin L, Jondet M. Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone. Mauritas 1993;16:185–202.
   PubMed Web of Science ®Google Scholar
• Liccardy FL, Kwiatkowski A, Noyes NL, Berkeley AS, Krey LL, Grifo JA. Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study. Fertil Steril 1999;71:614–618.
   PubMed Web of Science ®Google Scholar
• Simunic V, Tomic V, Tomic J, Nizic D. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support. Fertil Steril 2007;87:83–87.
   PubMed Web of Science ®Google Scholar
• Mitwally MF, Diamond MP, Abuzeid M. Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer. Fertil Steril 2010;93:554–569.
   PubMed Web of Science ®Google Scholar
• Khan N, Richter KS, Newsome TL, Blake EJ, Yankov VI. Matched-samples comparison of intramuscular versus vaginal progesterone for luteal phase support after in vitro fertilization and embryo transfer. Fertil Steril 2009;91:2445–2450.
   PubMed Web of Science ®Google Scholar
• Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein MD. Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of prospective randomized trial. Fertil Steril 2008;89:485–487.
   PubMed Web of Science ®Google Scholar
• Fanchin R, De Ziegler D, Bergeron C, Righini C, Torrisi C, Frydman R. Transvaginal administration of progesterone. Obstet Gynecol 1997;90:396–401.
   PubMed Web of Science ®Google Scholar
• Waren M, Biller B, Shangold M. A new clinical option for hormone replacement therapy in women with secondary amenorrhea: effect of cyclic administration of progesterone from the sustained-release vaginal gel Crinone (4% and 8%) on endometrial morphologic features and withdrawal bleeding. Am J Obstet Gynecol 1999;180:42–48.
   PubMed Web of Science ®Google Scholar
• Soliman S, Daya S, Collins J, Huges E. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 1994;61:1068–1076.
   PubMed Web of Science ®Google Scholar
• Smitz J, Devroey P, Braeckmans P, Camus M, Khan I, Staessen C, Van Waesberghe L, Wisanto A, Van Steirteghem AC. Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG. Hum Reprod 1987;2:309–314.
   PubMed Web of Science ®Google Scholar
• Kimzey LM, Gumowski J, Merriam GR, Nelson LM. Absorption of the micronized progesterone from a nonliquefying vaginal cream. Fertil Steril 1991;56:995–996.
   PubMed Web of Science ®Google Scholar
• Ficicioglu C. High local endometrial effect of vaginal progesterone gel. Gynecol Endocrinol 2004;18:240–243.
   PubMed Web of Science ®Google Scholar
• Whitehead MI, Townsend PT, Gill DK, Collins WP, Campbell S. Absorption and metabolism of oral progesterone. Br Med 1980;280:825–827.
   PubMedGoogle Scholar
• Arafat ES, Hargrove JT, Maxon WS, Desoderio DM, Wentz AC, Anderson RN. Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites. Am J Obstet Gynecol 1988;159: 1203–1209.
   PubMed Web of Science ®Google Scholar
• Norman TR, Morse CA, Dennerstein L. Comparative bioavailability of orally and vaginally administered progesterone. Fertil Steril 1991;56:1034–1039.
   PubMed Web of Science ®Google Scholar
• Propst AM, Hill JA, Ginsburg ES, Hurwitz S, Politch J, Yanushpolsky EH. A randomized study comparing Crinone 8% gel and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles. Fertil Steril 2001; 76:1144–1149.
   PubMed Web of Science ®Google Scholar
• Zarutskie PW, Phillips JA. A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone. Fertil Steril 2009;92:163–169.
   PubMed Web of Science ®Google Scholar
• Moyer DL, de Lignieres B, Driguez P, Pez JP. Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: influence of bleeding pattern and secretory changes. Fertil Steril 1993;59:992–997.
   PubMed Web of Science ®Google Scholar